Preschool Asthma

Listening to the words, asthma prevented her mother from being on his orbit, sent her heart to palpation, turned her idea into a whirlwind. Asthma means that a child can not breathe, and if a child can not breathe, that child will surely die. For parents who are not trained, this is the home information visited by a child's pediatrician. However, in most cases, death from asthma is not quite the case. Asthma does not need to define children, but rather is a chronic lung disease that forms part of many children's identity like a blue eye.

Many children are suffering from repeated coughing, wheezing, and chest tightness. Among pre-school children, one at 3 years complains of these symptoms by the age of 6, but only 40% of preschool children with these wheezons continue to have asthma . Most older children have asthma. The quality of life is affected by asthma management. Restriction of sleep disturbance and airflow caused by exercise may adversely affect participation in sports and social activities and may affect family life as well. The purpose of asthma treatment is to achieve asthma management, but only a small number of patients can achieve complete control. This may be due to misdiagnosis, co-morbidity, or poor inhalation technology, but in most cases compliance failure is the main cause of treatment failure. However, building partnerships with parents and children is important to set personally selected treatment goals and may help improve management.

Inhaled corticosteroid therapy is the cornerstone of asthma and asthma treatment in preschool children. All children should use short acting beta 2 agonists as relief therapy if necessary. Long-acting beta 2 agonists are not recommended for ages 5 and under because of insufficient tests and lack of safety data. The GINA guidelines recommend increasing the dose of ICS or adding LABA and / or montelukast if asthma is not adequately controlled at low to moderate doses of ICS. Evidence of these steps is limited. Starting with LABA, only one study showed that many children will benefit by doubling the dose of ICS and adding Montelukast as it seems to be effective for most children . This indicates that clinicians should try individual treatments